Aster DM Quality Care Limited (NSE:ASTERDM)
India · Delayed Price · Currency is INR | Market Cap | 617.00B +90.4% |
| Revenue (ttm) | 48.76B +15.7% |
| Net Income | 3.19B +0.2% |
| EPS | 6.16 -2.9% |
| Shares Out | 870.36M |
| PE Ratio | 115.15 |
| Forward PE | 42.97 |
| Dividend | 5.00 (0.71%) |
| Ex-Dividend Date | Apr 2, 2026 |
| Volume | 1,534,481 |
| Open | 694.05 |
| Previous Close | 697.15 |
| Day's Range | 684.25 - 712.20 |
| 52-Week Range | 519.10 - 891.30 |
| Beta | -0.08 |
| Analysts | Buy |
| Price Target | 928.08 (+31.09%) |
| Est. Earnings | Nov 6, 2026 |
About Aster DM Quality Care
Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through Hospitals & Clinics, Labs, Wholesale Pharmacies, and Others segments. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care in various specialty areas, including multi-specialty, cardiac sciences, OP pharmacy, anaesthesiology and others, neuro sciences, oncology, gastroenterology and integrated liver care, nephrology and urology, orthopaedics, women’s health, and child adolescent hea... [Read more]
Financial Performance
In fiscal year 2026, Aster DM Quality Care's revenue was 46.43 billion, an increase of 12.20% compared to the previous year's 41.38 billion. Earnings were 3.88 billion, a decrease of -92.78%.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for ASTERDM stock is "Buy." The 12-month stock price target is ₹928.08, which is an increase of 31.09% from the latest price.
News
Aster DM Quality Care Transcript: Q1 26/27
The merged entity delivered robust Q1 FY 2027 results, with 20% revenue and 30% EBITDA growth year-on-year, driven by strong patient volumes, operational leverage, and expansion into new markets. Management targets 24%-25% EBITDA margin within three years and expects significant synergy benefits.
Aster DM Quality Care Quarterly report: Q1 2027
Aster DM Quality Care has published its Q1 2027 quarterly earnings report on August 5, 2026.
Aster DM Quality Care Slides: Q1 2027
Aster DM Quality Care has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 5, 2026.
Aster DM Healthcare designates KMP for materiality determination under SEBI regulations
Aster DM Healthcare has formally designated its Key Managerial Personnel (KMP) authorised to determine the materiality of events or information and make disclosures to stock exchanges, in accordance w...
Aster DM Healthcare announces effective date for amalgamation scheme with Quality Care India
Aster DM Healthcare Limited has announced the effective date for its Scheme of Amalgamation with Quality Care India Limited (QCIL). The scheme, which involves the amalgamation of QCIL into Aster…
Aster DM Healthcare acquires Rs 25 crore preference shares in Alfaone Medicals
Aster DM Healthcare has announced the acquisition of 3,57,143 Optionally Convertible Redeemable Preference Shares (OCRPS) in Alfaone Medicals Private Limited for a total consideration of ₹25 crore. Th...
Aster DM Healthcare receives NCLT approval for amalgamation scheme
Aster DM Healthcare has received a certified true copy of the order from the National Company Law Tribunal (NCLT), Hyderabad Bench, approving the Scheme of Amalgamation with Quality Care India…
Aster DM Healthcare subsidiary allots 12 lakh Series A CCPS
Aster DM Healthcare's subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, has announced the allotment of 12,00,000 fully paid-up Series A Compulsorily Convertible Preference Shar...
Aster DM Healthcare receives NCLT approval for amalgamation with Quality Care India
Aster DM Healthcare has received approval from the National Company Law Tribunal (NCLT), Hyderabad Bench, for its Scheme of Amalgamation with Quality Care India Limited (QCIL). The tribunal sanctioned...
Aster DM Healthcare acquires equity shares worth Rs 45.08 crore in Sarjapur entity
Aster DM Healthcare has acquired 4,50,89,995 equity shares in its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, through a rights issue. The acquisition, valued at ₹45,08,99...
Aster DM subsidiary allots 21,40,000 Series A CCPS and 18,40,000 Series B CCPS
Aster DM Healthcare's subsidiary, Aster DM Multispecialty Hospital Private Limited (ADMPL), has announced the allotment of 21,40,000 fully paid-up Series A Compulsorily Convertible Preference Shares (...
Aster DM Quality Care Slides: Investor presentation
Aster DM Quality Care has posted slides in relation to its latest quarterly earnings report, which was published on June 3, 2026.
Aster DM Healthcare shares surge over 10% after strong Q4 Results; Net profit jumps 80.4% YoY
Shares of Aster DM Healthcare rallied more than 10% in early trade on Monday after the company reported a strong set of earnings for the fourth quarter of FY26, driven…
Aster DM Quality Care Transcript: Q4 25/26
The group delivered strong double-digit revenue and EBITDA growth in Q4 and FY 2026, driven by higher patient volumes, improved case mix, and disciplined expansion. The merger with Quality Care is on track, with significant capacity additions and margin expansion expected post-merger.
Aster DM Quality Care Quarterly report: Q4 2026
Aster DM Quality Care has published its Q4 2026 quarterly earnings report on May 1, 2026.
Aster DM Quality Care Slides: Q4 2026
Aster DM Quality Care has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 1, 2026.
Stocks to buy: What's the outlook for Nifty for April 27-April 30 week? Check list of top stock recommendations
Stock market recommendations: Aster DM Healthcare, and GE Vernova T&D India have been picked by Sudeep Shah, Head - Technical Research and Derivatives, SBI Securities as the top stocks to buy this wee...
Stocks to buy: What's the outlook for Nifty for March 30-April 3 week? Check list of top stock recommendations
Stock market recommendations: Aster DM Healthcare, and Karur Vysya Bank are the top stocks that have been recommended by Sudeep Shah, Head - Technical Research and Derivatives, SBI Securities for the ...
Aster DM Healthcare announces Rs 3 interim dividend per share for FY 2025-26
Aster DM Healthcare has declared an interim dividend of ₹3 per equity share for the financial year 2025-26. The announcement was made during the Board of Directors meeting held on…
Aster DM Healthcare secures 96.68% shareholder approval for merger with QCIL
Aster DM Healthcare Limited has received an overwhelming 96.68% voting approval from its shareholders for the proposed merger with Quality Care India Limited (QCIL). The merger is set to create…
Aster DM Healthcare secures 100% approval for amalgamation scheme from creditors
Aster DM Healthcare's unsecured trade creditors have overwhelmingly approved the Scheme of Amalgamation with Quality Care India Limited. The resolution received 100% votes in favour from the creditors...
Aster DM Healthcare appoints Dr. Azad Moopen as Executive Director
Aster DM Healthcare has announced the appointment of Dr. Azad Moopen as Executive Director, effective from 15 April 2026 to 28 May 2028. This decision was made during the company's…
Pharma sector stocks today, Feb 11: Aster DM Healthcare up 2.39%, Jeena Sikho down 2.75%, Concord Biotech falls 2.10%
The Indian pharmaceutical sector showed mixed performance on February 11, 2026, as of around 10:20 AM IST. The Nifty Pharma...
Aster DM Quality Care Transcript: Q3 25/26
Combined Aster and Quality Care delivered robust double-digit revenue and EBITDA growth, with strong performance across clusters and ongoing capacity expansion. Margin resilience was maintained despite investments in talent and new projects, while the merger process advanced and synergy realization is expected to drive further margin improvement.
Aster DM Quality Care Quarterly report: Q3 2026
Aster DM Quality Care has published its Q3 2026 quarterly earnings report on February 2, 2026.